• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
When to Screen in Obstetrics and Gynecology

When to Screen in Obstetrics and Gynecology

9781416003007
322.51 zł
290.26 zł Save 32.25 zł Tax included
Lowest price within 30 days before promotion: 290.26 zł
Quantity
Product unavailable
Out of print

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
When to Screen in Obstetrics and Gynecology is a resource designed to assist obstetricians and gynecologists, midwives, and family practitioners in making some complex decisions regarding screening tests by providing the following considerations:: what is the problem that requires screening; the tests; and conclusions and recommendations.
Product Details
Saunders
37429
9781416003007
9781416003007

Data sheet

Publication date
2006
Issue number
2
Cover
paperback
Pages count
704
Dimensions (mm)
152 x 229
Weight (g)
971
  • 1 Epidemiologic Considerations in Screening
    2 Maternal Red Blood Cell Group and Antibody Screen
    3 Antepartum Assessment of Hemoglobin, Hematocrit, and Serum Ferritin
    4 Postpartum Assessment of Hemoglobin, Hematocrit, and Serum Ferritin
    5 Asymptomatic Bacteriuria in Pregnancy
    6 Neonatal Group B Streptococcal Disease
    7 Rubella During Pregnancy
    8 Congenital Toxoplasmosis
    9 Congenital Cytomegalovirus Infection
    10 Hepatitis A, B, and C During Pregnancy
    11 Syphilis
    12 Gonorrhea
    13 Chlamydial Infection
    14 HIV Infection
    15 Screening for Cystic Fibrosis Carrier Status
    16 Screening for Hemoglobinopathies
    17 Early-onset Genetic Disease
    18 Screening for Fragile X Syndrome
    19 Screening for Huntington Disease
    20 Routine Ultrasound for Dating
    21 First Trimester Screening for Aneuploidy
    22 Second Trimester Screening for Aneuploidy (Ultrasound and Biochemistry)
    23 Biochemical Screening for Fetal Abnormalities
    24 Routine Ultrasonography for the Detection of Fetal Structural Anomalies
    25 Molecular Tests for Antenatal Detection of Aneuploidy
    26 Thrombophilia and Pregnancy Complications: Preeclampsia, (Late) Intrauterine Fetal Death, and Thrombosis
    27 Screening for Autoimmune Diseases in Pregnancy
    28 Gestational Diabetes Mellitus
    29 Screening for Low Birth Weight Using Maternal Height and Weight
    30 Fundal Height Measurement
    31 Fetal Growth Restriction
    32 Doppler Velocimetry for the Detection of Intrauterine Growth Restriction
    33 Preterm Delivery
    34 Preeclampsia: Blood Pressure, Weight Gain, and Edema
    35 Uterine Artery Doppler as Screening Tool for Preeclampsia
    36 Preeclampsia and Uric Acid
    37 Fetal Hypoxia
    38 Peripartum Coagulopathy
    39 Postpartum Umbilical Cord Blood Testing
    40 When to Screen for Neonatal Hypoglycemia
    41 Neonatal Hyperbilirubinemia
    42 Screening for Neonatal Genetic Disorders
    43 The Annual Bimanual Examination
    44 Dyslipidemia
    45 Diabetes Mellitus
    46 Screening Tests for Contraceptive Users
    47 Genetic Predisposition to Gynecologic Cancers
    48 Screening for Breast Cancer
    49 Pap Smear
    50 High-Risk Human Papillomavirus Testing in Cervical Cancer Screening
    51 Transvaginal Ultrasound as a Screening Method for Ovarian Cancer
    52 Serum CA-125 Screening for Ovarian Cancer
    53 Screening for Colorectal Cancer
    54 The Electrocardiogram
    55 Intravenous Pyleography
    56 Osteoporosis
    Index
Comments (0)